Biotech headwinds are driving double-digit revenue growth and profitability for these two mid-caps.

The biotech sector is one that’s become red-hot, at least in recent years. After around a decade of stagnation, investors ...

Shares of biotech companies were outpacing the broader market on Thursday. The State Street SPDR S&P Biotech ETF was up 2.7%, compared with the 0.8% gain of the S&P 500. A significant portion of these ...

This biotech has candidates in late-stage clinical development.

The words “sure-fire” and biotechnology stocks rarely go together. This is a sector of the stock market that carries ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

With partner Eli Lilly’s help, the radiopharmaceutical drugmaker priced one of the sector’s largest new stock offerings in the last two years.

In this article, we will take a look at 9 Oversold Biotech Stocks to Invest In. Biotech companies are making a solid comeback following an extended slump as investors shift their focus back to value ...

The volatile biotech industry has put up a strong performance in 2025 despite the uncertain macroeconomic environment. While the tariff saga hit the pharma/biotech industry earlier in the year, the ...

Local biotech entrepreneurs and investors are seeing signs that the four-year "biotech winter" is finally thawing, though ...